ICD-10

ICD-10 code I69.36

You are here: Home > ICD-10-CM > I00-I99 > I60-I69 > I69 > I69.3

- ICD-10-CM
TABULAR LIST of DISEASES and INJURIES
- I00-I99
Diseases of the circulatory system
- I60-I69
Cerebrovascular diseases
- I69
Sequelae of cerebrovascular disease
- I69.3
Sequelae of cerebral infarction

I69.36

Other paralytic syndrome following cerebral infarction

ICD-10 code I69.36 for Other paralytic syndrome following cerebral infarction

Use additional code to identify type of paralytic syndrome, such as:
locked-in state (G83.5)
quadriplegia (G82.5-)
Excludes1: hemiplegia/hemiparesis following cerebral infarction (I69.35-)
monoplegia of lower limb following cerebral infarction (I69.34-)
monoplegia of upper limb following cerebral infarction (I69.33-)
I69.361
Other paralytic syndrome following cerebral infarction affecting right dominant side
I69.362
Other paralytic syndrome following cerebral infarction affecting left dominant side
I69.363
Other paralytic syndrome following cerebral infarction affecting right non-dominant side
I69.364
Other paralytic syndrome following cerebral infarction affecting left non-dominant side
I69.365
Other paralytic syndrome following cerebral infarction, bilateral
I69.369
Other paralytic syndrome following cerebral infarction affecting unspecified side
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us